Portola Pharms Inc Drug Patent Portfolio
Portola Pharms Inc owns 1 orange book drug protected by 10 US patents Given below is the list of Portola Pharms Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8404724 | Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor | 29 Mar, 2031 | Active |
| US8987463 | Methods of synthesizing factor Xa inhibitors | 28 Dec, 2030 | Active |
| US8557852 | Methods of using crystalline forms of a salt of a factor Xa inhibitor | 08 Sep, 2028 | Active |
| US7598276 | Pharmaceutical salts and polymorphs of a factor Xa inhibitor | 08 Nov, 2026 | Active |
| US9555023 | Pharmaceutical salts and polymorphs of a factor Xa inhibitor | 07 Nov, 2026 | Active |
| US6376515 | Benzamides and related inhibitors of factor Xa | 15 Sep, 2020 | Expired |
| US6835739 | Benzamides and related inhibitors of factor Xa | 15 Sep, 2020 | Expired |
| US8518977 | Benzamides and related inhibitors of factor XA | 15 Sep, 2020 | Expired |
| US8691847 | Benzamides and related inhibitors of factor Xa | 15 Sep, 2020 | Expired |
| US9629831 | Benzamides and related inhibitors of factor XA | 15 Sep, 2020 | Expired |
Latest Legal Activities on Portola Pharms Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Portola Pharms Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 16 May, 2022 | US8691847 |
|
Maintenance Fee Reminder Mailed
Critical
| 29 Nov, 2021 | US8691847 |
|
Expire Patent
Critical
| 22 Nov, 2021 | US8557852 |
|
Expire Patent
Critical
| 04 Oct, 2021 | US8518977 |
|
Maintenance Fee Reminder Mailed
Critical
| 07 Jun, 2021 | US8557852 |
|
Expire Patent
Critical
| 31 May, 2021 | US9629831 |
|
Expire Patent
Critical
| 03 May, 2021 | US8404724 |
|
Maintenance Fee Reminder Mailed
Critical
| 19 Apr, 2021 | US8518977 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 06 Apr, 2021 | US7598276 |
|
Maintenance Fee Reminder Mailed
Critical
| 14 Dec, 2020 | US9629831 |
|
Maintenance Fee Reminder Mailed
Critical
| 16 Nov, 2020 | US8404724 |
|
Patent Term Extension (156) Dismissed
Critical
| 14 Oct, 2020 | US6835739 |
|
Patent Term Extension (156) Dismissed
Critical
| 14 Oct, 2020 | US7598276 |
|
Patent Term Extension (156) Dismissed
Critical
| 14 Oct, 2020 | US6376515 |
|
Patent Term Extension (156) Dismissed
Critical
| 14 Oct, 2020 | US8518977 |
Portola Pharms Inc Drug Patents' Oppositions Filed in EPO
Portola Pharms Inc drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Nov 18, 2013, by Zentiva K.S.. This opposition was filed on patent number EP07864488A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP07864488A | Nov, 2013 | Sölch, Günter | Revoked |
| EP07864488A | Nov, 2013 | Zentiva k.s. | Revoked |
Portola Pharms Inc's Family Patents
Portola Pharms Inc Drug List
Given below is the complete list of Portola Pharms Inc's drugs and the patents protecting them.
1. Bevyxxa
Bevyxxa is protected by 10 patents, out of which 5 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8404724 | Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor |
29 Mar, 2031
(6 years from now)
| Active |
| US8987463 | Methods of synthesizing factor Xa inhibitors |
28 Dec, 2030
(6 years from now)
| Active |
| US8557852 | Methods of using crystalline forms of a salt of a factor Xa inhibitor |
08 Sep, 2028
(3 years from now)
| Active |
| US7598276 | Pharmaceutical salts and polymorphs of a factor Xa inhibitor |
08 Nov, 2026
(1 year, 11 months from now)
| Active |
| US9555023 | Pharmaceutical salts and polymorphs of a factor Xa inhibitor |
07 Nov, 2026
(1 year, 11 months from now)
| Active |
| US6376515 | Benzamides and related inhibitors of factor Xa |
15 Sep, 2020
(4 years ago)
| Expired |
| US6835739 | Benzamides and related inhibitors of factor Xa |
15 Sep, 2020
(4 years ago)
| Expired |
| US8518977 | Benzamides and related inhibitors of factor XA |
15 Sep, 2020
(4 years ago)
| Expired |
| US8691847 | Benzamides and related inhibitors of factor Xa |
15 Sep, 2020
(4 years ago)
| Expired |
| US9629831 | Benzamides and related inhibitors of factor XA |
15 Sep, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Bevyxxa's drug page